Skip to content
value.today
Xbrane Biopharma AB (publ) logo

Xbrane Biopharma AB (publ)

XBRANE.ST
$29 Mlast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
—
annual
Net income
—
Employees
—

Xbrane Biopharma AB (publ) in brief

Xbrane Biopharma AB (publ) is a listed company in the Biotechnology industry, based in Sweden. Its last known market value was $29 M (January 2024); there is no current figure. Its shares trade under the symbol XBRANE.ST (Stockholm).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

Market cap history

$0 M$76 M$153 M$229 M$306 M20202021202220232024

World rank over time

▼ down 6,140 places since 2020
2020-01-01: #21204#21,20420202021-01-01: #15475#15,47520212022-01-07: #17026#17,02620222022-12-25: #18000#18,00020222023-07-30: #17843#17,84320232024-01-05: #27344#27,3442024

Rank in Sweden: #339 (Jan 2020) · #260 (Jan 2021) · #256 (Jan 2022) · #240 (Dec 2022) · #233 (Jul 2023) · #426 (Jan 2024)

FDA drug approvals: Xbrane Biopharma AB (publ)#

1 approved applications held; 1 approvals and 0 new uses in 2026.

Approvals held
1
New molecular entities
0
New uses approved
0
efficacy supplements
Generics
0
0 new drugs, 1 biologics
Xbrane Biopharma AB (publ): latest FDA approvals
ApprovedDrugKind
2026-10-27LucamziRanibizumab-Blrz · BLA761187Biologic (BLA)

Source: Drugs@FDA (openFDA). Approvals are listed under the application's current holder (XBRANE BIOPHARMA AB), so they follow acquisitions

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Xbrane Biopharma AB (publ)🇸🇪$29 M———
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 5, 2024 (last known)
Profile updated:
Nov 15, 2026

Figures from value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Xbrane Biopharma AB (publ)? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Xbrane Biopharma AB (publ)'s ranking on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Xbrane Biopharma AB (publ)? Suggest a correction